Market Overview:
The East Africa generic drug market is currently witnessing moderate growth. Generic drugs are medications that contain the same active ingredients and have the same therapeutic effect as their branded counterparts. These drugs may differ in packaging but are identical in quality, strength, dosage, performance, and efficiency. As they are cost-efficient, the demand for generic drugs is escalating in the East African region.
The market is primarily driven by rapid urbanization, along with improving infrastructure and healthcare facilities in the East African region. Apart from this, governments of different countries in the region are introducing price control policies and import restrictions to encourage domestic drug manufacturing. This, in turn, is propelling the growth of the generic drugs market. However, the market experienced a negative impact on account of the sudden outbreak of the coronavirus disease (COVID-19), the imposition of lockdown restrictions, hindrances in international trade and a temporary halt in the operations of several manufacturing units. The market will witness growth once COVID-19 cases reduce, operations at these manufacturing units resume and lockdown relaxations are uplifted in the region. Looking forward, the market is expected to continue its moderate growth during the forecast period (2021-2026).
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the East Africa generic drug market report, along with forecasts for growth at the region level from 2021-2026. Our report has categorized the market based on region, segment, therapy area, drug delivery and distribution channel.
Breakup by Segment:
- Unbranded Generics
- Branded Generics
Breakup by Therapy Area:
- Central Nervous System
- Cardiovascular
- Dermatology
- Genitourinary/Hormonal
- Respiratory
- Rheumatology
- Diabetes
- Oncology
- Others
Breakup by Drug Delivery:
- Oral
- Injectables
- Dermal/Topical
- Inhalers
Breakup by Distribution Channel:
- Retail Pharmacies
- Hospital Pharmacies
Breakup by Country:
- Uganda
- Burundi
- Rwanda
- Kenya
- Tanzania
- Others
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Key Questions Answered in This Report:
- How has the East Africa generic drug market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the East Africa generic drug market?
- What are the key regional markets?
- What is the breakup of the market based on the segment?
- What is the breakup of the market based on the therapy area?
- What is the breakup of the market based on the drug delivery?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the market?
- What is the structure of the East Africa generic drug market and who are the key players?
- What is the degree of competition in the market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 East Africa Generic Drug Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Segment
6.1 Unbranded Generics
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Branded Generics
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Therapy Area
7.1 Central Nervous System
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cardiovascular
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Dermatology
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Genitourinary/Hormonal
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Respiratory
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Rheumatology
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Diabetes
7.7.1 Market Trends
7.7.2 Market Forecast
7.8 Oncology
7.8.1 Market Trends
7.8.2 Market Forecast
7.9 Others
7.9.1 Market Trends
7.9.2 Market Forecast
8 Market Breakup by Drug Delivery
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Injectables
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Dermal/Topical
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Inhalers
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Retail Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospital Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Country
10.1 Uganda
10.1.1 Market Trends
10.1.2 Market Breakup by Segment
10.1.3 Market Breakup by Therapy Area
10.1.4 Market Breakup by Drug Delivery
10.1.5 Market Breakup by Distribution Channel
10.1.6 Market Forecast
10.2 Burundi
10.2.1 Market Trends
10.2.2 Market Breakup by Segment
10.2.3 Market Breakup by Therapy Area
10.2.4 Market Breakup by Drug Delivery
10.2.5 Market Breakup by Distribution Channel
10.2.6 Market Forecast
10.3 Rwanda
10.3.1 Market Trends
10.3.2 Market Breakup by Segment
10.3.3 Market Breakup by Therapy Area
10.3.4 Market Breakup by Drug Delivery
10.3.5 Market Breakup by Distribution Channel
10.3.6 Market Forecast
10.4 Kenya
10.4.1 Market Trends
10.4.2 Market Breakup by Segment
10.4.3 Market Breakup by Therapy Area
10.4.4 Market Breakup by Drug Delivery
10.4.5 Market Breakup by Distribution Channel
10.4.6 Market Forecast
10.5 Tanzania
10.5.1 Market Trends
10.5.2 Market Breakup by Segment
10.5.3 Market Breakup by Therapy Area
10.5.4 Market Breakup by Drug Delivery
10.5.5 Market Breakup by Distribution Channel
10.5.6 Market Forecast
10.6 Others
10.6.1 Market Trends
10.6.2 Market Breakup by Segment
10.6.3 Market Breakup by Therapy Area
10.6.4 Market Breakup by Drug Delivery
10.6.5 Market Breakup by Distribution Channel
10.6.6 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Policy and Regulatory Landscape
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
List of Figures
Figure 1: East Africa: Generic Drug Market: Major Drivers and Challenges
Figure 2: East Africa: Generic Drug Market: Sales Value (in Million US$), 2015-2020
Figure 3: East Africa: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: East Africa: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 5: East Africa: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 6: East Africa: Generic Drug Market: Breakup by Drug Delivery (in %), 2020
Figure 7: East Africa: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 8: East Africa: Generic Drug Market: Breakup by Country (in %), 2020
Figure 9: East Africa: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: East Africa: Generic Drug (Unbranded Generics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: East Africa: Generic Drug (Unbranded Generics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: East Africa: Generic Drug (Branded Generics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: East Africa: Generic Drug (Branded Generics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: East Africa: Generic Drug (Central Nervous System) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: East Africa: Generic Drug (Central Nervous System) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: East Africa: Generic Drug (Cardiovascular) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: East Africa: Generic Drug (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: East Africa: Generic Drug (Dermatology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: East Africa: Generic Drug (Dermatology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: East Africa: Generic Drug (Genitourinary/Hormonal) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: East Africa: Generic Drug (Genitourinary/Hormonal) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: East Africa: Generic Drug (Respiratory) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: East Africa: Generic Drug (Respiratory) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: East Africa: Generic Drug (Rheumatology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: East Africa: Generic Drug (Rheumatology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: East Africa: Generic Drug (Diabetes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: East Africa: Generic Drug (Diabetes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: East Africa: Generic Drug (Oncology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: East Africa: Generic Drug (Oncology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: East Africa: Generic Drug (Other Therapy Areas) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: East Africa: Generic Drug (Other Therapy Areas) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: East Africa: Generic Drug (Oral) Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: East Africa: Generic Drug (Oral) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: East Africa: Generic Drug (Injectables) Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: East Africa: Generic Drug (Injectables) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: East Africa: Generic Drug (Dermal/Topical) Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: East Africa: Generic Drug (Dermal/Topical) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: East Africa: Generic Drug (Inhalers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: East Africa: Generic Drug (Inhalers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: East Africa: Generic Drug (Retail Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: East Africa: Generic Drug (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: East Africa: Generic Drug (Hospital Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: East Africa: Generic Drug (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Uganda: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Uganda: Generic Drug Market: Breakup by Product (in %), 2020
Figure 46: Uganda: Generic Drug Market: Breakup by Type (in %), 2020
Figure 47: Uganda: Generic Drug Market: Breakup by Packaging Type (in %), 2020
Figure 48: Uganda: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 49: Uganda: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Burundi: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Burundi: Generic Drug Market: Breakup by Product (in %), 2020
Figure 52: Burundi: Generic Drug Market: Breakup by Type (in %), 2020
Figure 53: Burundi: Generic Drug Market: Breakup by Packaging Type (in %), 2020
Figure 54: Burundi: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 55: Burundi: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Rwanda: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Rwanda: Generic Drug Market: Breakup by Product (in %), 2020
Figure 58: Rwanda: Generic Drug Market: Breakup by Type (in %), 2020
Figure 59: Rwanda: Generic Drug Market: Breakup by Packaging Type (in %), 2020
Figure 60: Rwanda: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 61: Rwanda: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Kenya: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Kenya: Generic Drug Market: Breakup by Product (in %), 2020
Figure 64: Kenya: Generic Drug Market: Breakup by Type (in %), 2020
Figure 65: Kenya: Generic Drug Market: Breakup by Packaging Type (in %), 2020
Figure 66: Kenya: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 67: Kenya: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Tanzania: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Tanzania: Generic Drug Market: Breakup by Product (in %), 2020
Figure 70: Tanzania: Generic Drug Market: Breakup by Type (in %), 2020
Figure 71: Tanzania: Generic Drug Market: Breakup by Packaging Type (in %), 2020
Figure 72: Tanzania: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 73: Tanzania: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Others: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: Others: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: East Africa: Generic Drug Industry: SWOT Analysis
Figure 77: East Africa: Generic Drug Industry: Value Chain Analysis
Figure 78: East Africa: Generic Drug Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: East Africa: Generic Drug Market: Key Industry Highlights, 2020 and 2026
Table 2: East Africa: Generic Drug Market Forecast: Breakup by Segment (in Million US$), 2021-2026
Table 3: East Africa: Generic Drug Market Forecast: Breakup by Therapy Area (in Million US$), 2021-2026
Table 4: East Africa: Generic Drug Market Forecast: Breakup by Drug Delivery (in Million US$), 2021-2026
Table 5: East Africa: Generic Drug Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 6: East Africa: Generic Drug Market Forecast: Breakup by Country (in Million US$), 2021-2026
Table 7: East Africa: Generic Drug Market: Key Players